Source: Manufacturing Chemist

Abzena: AbZelectPRO enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L

The platform can assist biopharma professionals in optimising their protein production processes, reducing timelines by more than 30%

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Matthew Stober's photo - CEO of Abzena

CEO

Matthew Stober

CEO Approval Rating

82/100

Read more